TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Macrophage nuclear receptors: Emerging key players in infectious diseases

(2019) Chrissy M. Leopold Wager et al.   PLoS Pathogens

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

(2018) Fan Feng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

A human xenobiotic nuclear receptor contributes to nonresponsiveness ofMycobacterium tuberculosisto the antituberculosis drug rifampicin

(2018) Ella Bhagyaraj et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363

(2018) Hai Huang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR

(2018) Zhiyi Shao et al.   PHARMACOLOGICAL RESEARCH

Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib

(2017) Dongxu Kang et al.   YONSEI MEDICAL JOURNAL

TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment

(2017) Michael W. Pickup et al.   Cold Spring Harbor Perspectives in Biology

The rationale for targeting TGF-β in chronic liver diseases

(2016) Gianluigi Giannelli et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE

(2016) Ankita Saini et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer

(2016) Yang Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Human Xenobiotic Nuclear Receptor PXR AugmentsMycobacterium tuberculosisSurvival

(2016) Ella Bhagyaraj et al.   JOURNAL OF IMMUNOLOGY

TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells

(2016) Nathan Ungerleider et al.   MOLECULAR CARCINOGENESIS

Pregnane and Xenobiotic Receptor gene expression in liver cells is modulated by Ets-1 in synchrony with transcription factors Pax5, LEF-1 and c-jun

(2015) Sangeeta Kumari et al.   EXPERIMENTAL CELL RESEARCH

The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates Extracellular Signal-regulated Kinase (ERK) to Inhibit the Differentiation of a Inflammatory T Helper Cell Subset and Suppress Experimental Autoimmune Encephalomyelitis

(2015) Ravikanth Nanduri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

(2015) William H. Chappell et al.   Oncotarget

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

(2015) Melchiorre Cervello et al.   Oncotarget

ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells

(2014) Joshua P. Plotnik et al.   NUCLEIC ACIDS RESEARCH

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer

(2014) Kenji Takahashi et al.   FEBS Open Bio

TGF-β: An emerging player in drug resistance

(2013) Diede Brunen et al.   CELL CYCLE

Epidemiology of Hepatocellular Carcinoma

(2013) Sahil Mittal et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation

(2011) Raquel Urtasun et al.   HEPATOLOGY

Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF- -Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4

(2009) L. Caja et al.   CANCER RESEARCH

Paclitaxel-resistance Conferred by Altered Expression of Efflux and Influx Transporters for Paclitaxel in the Human Hepatoma Cell Line, HepG2

(2009) Mikihisa Takano et al.   Drug Metabolism and Pharmacokinetics

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY

The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells

(2007) Jie Zhou et al.   MOLECULAR ENDOCRINOLOGY